OTC Markets OTCPK - Delayed Quote USD

Endexx Corporation (EDXC)

0.0054
+0.0004
+(8.00%)
At close: May 16 at 3:54:26 PM EDT
Loading Chart for EDXC
  • Previous Close 0.0050
  • Open 0.0054
  • Bid 0.0050 x --
  • Ask 0.0054 x --
  • Day's Range 0.0054 - 0.0054
  • 52 Week Range 0.0014 - 0.0222
  • Volume 500
  • Avg. Volume 427,684
  • Market Cap (intraday) 3.088M
  • Beta (5Y Monthly) -0.43
  • PE Ratio (TTM) 0.54
  • EPS (TTM) 0.0100
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Endexx Corporation engages in the manufacturing and sale of cannabidiol (CBD)-based products for the health and wellness market. The company provides oils, extracts, topicals, and pet products for supporting the relief of pain and inflammation for humans and pets through its e-commerce site cbdunlimited.com, as well as other online and in-store retailers. It also offers hemp-derived oils, topical skin care for skin health, and beauty products, hemp-derived creams and balms, a premium line of hemp-derived health and beauty care products, and organic, plant-based, all-natural, zero-nicotine, tobacco-free vape products, as well as PhytoBites, a hemp-derived soft chews for animals. The company was formerly known as CBD Unlimited, Inc. and changed its name to Endexx Corporation in May 2020. Endexx Corporation is headquartered in Cave Creek, Arizona.

www.endexx.com

--

Full Time Employees

September 30

Fiscal Year Ends

Recent News: EDXC

View More

Performance Overview: EDXC

Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

EDXC
21.74%
S&P 500 (^GSPC)
1.30%

1-Year Return

EDXC
73.00%
S&P 500 (^GSPC)
12.48%

3-Year Return

EDXC
82.12%
S&P 500 (^GSPC)
48.66%

5-Year Return

EDXC
92.56%
S&P 500 (^GSPC)
108.07%

Compare To: EDXC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: EDXC

View More

Valuation Measures

Annual
As of 5/16/2025
  • Market Cap

    3.09M

  • Enterprise Value

    17.53M

  • Trailing P/E

    0.54

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.73

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    4.64

  • Enterprise Value/EBITDA

    2.16

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    148.63%

  • Return on Assets (ttm)

    -31.03%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    4.64M

  • Net Income Avi to Common (ttm)

    6.89M

  • Diluted EPS (ttm)

    0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    23.73k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -4.01M

Research Analysis: EDXC

View More

Company Insights: EDXC

Research Reports: EDXC

View More

People Also Watch